EUVIMEDEUVIMED entdecken
Crossref

2616-P: Leptin Pathway Dysregulation in African Americans with Type 2 Diabetes

SYDNEY I. ALLISON, TANMOY MONDAL, CHRISTOPHER LOFFREDO, RUTH QUARTEY, BRENT KORBA, GAIL NUNLEE-BLAND, SOMIRANJAN GHOSH

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2616-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von SYDNEY I. ALLISON und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Leptin (LEP), an adipocyte-derived hormone, plays a central role in energy homeostasis and insulin sensitivity. Dysregulation of LEP signaling has been connected to obesity associated T2D; however, population-specific molecular evidence in African Americans (AAs) remains limited. We aimed to characterize LEP-associated transcriptional alterations and pathway dysregulation in AA adults with T2D from the DC area.

Methods

Whole-blood RNA sequencing was performed on 34 AA participants recruited from the Diabetes Center, including T2D (n=23) and non-T2D controls (n=11). The sociodemographic, lifestyle, and medical histories were recorded. Differential gene expression analysis was conducted using Illumina sequencing, followed by Ingenuity Pathway Analysis to identify LEP-related signaling networks.

Results

LEP (FC= -1.65) expression was significantly downregulated in T2D compared to controls. Pathway analysis revealed disrupted LEPR-mediated signaling in hypothalamic NPY/AgRP and POMC neuronal pathways, characterized by SOCS3 upregulation and inhibition of JAK-STAT signaling. This suppression promoted persistent nuclear FOXO1 activity, increased orexigenic NPY/AgRP expression, impaired appetite suppression, and features consistent with leptin resistance.

Conclusion

These findings demonstrate LEP pathway dysregulation at the transcriptomic level in AAs with T2D, providing mechanistic insight into leptin resistance and metabolic dysfunction. Disclosure S.I. Allison: None. T. Mondal: None. C. Loffredo: None. R. Quartey: None. B. Korba: None. G. Nunlee-Bland: None. S. Ghosh: None. Funding National Institutes of Health (MD007597-31-5959)

Zitieren

APA

ALLISON, S. I., MONDAL, T., LOFFREDO, C., QUARTEY, R., KORBA, B., NUNLEE-BLAND, G., & GHOSH, S. (2026). 2616-P: Leptin Pathway Dysregulation in African Americans with Type 2 Diabetes. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2616-p

Vancouver

ALLISON SI, MONDAL T, LOFFREDO C, QUARTEY R, KORBA B, NUNLEE-BLAND G, et al. 2616-P: Leptin Pathway Dysregulation in African Americans with Type 2 Diabetes. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2616-p

BibTeX
@article{ALLISON2026,
  author = {ALLISON, SYDNEY I. and MONDAL, TANMOY and LOFFREDO, CHRISTOPHER and QUARTEY, RUTH and KORBA, BRENT and NUNLEE-BLAND, GAIL and GHOSH, SOMIRANJAN},
  title = {2616-P: Leptin Pathway Dysregulation in African Americans with Type 2 Diabetes},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2616-p}
}
Kostenlos starten →